Gilead kickstarts patent pool for AIDS drugs
Gilead kickstarts patent pool for AIDS drugs
LONDON (Reuters) – Gilead Sciences, the leading maker of HIV drugs, is to share intellectual property rights on its medicines in a patent pool designed to make treatments more widely available to the poor.